Start low, go slow For any new peptide: Start at lowest effective dose Assess tolerance for 1-2 weeks Increase gradually if needed Don't rush to maximum dose Example progression: BPC-157: Start 250mcg 2x daily, can increase to 500mcg 2x daily if needed CJC/Ipa: Start 200mcg each, can increase to 300mcg if no sides Monitor for side effects Common across peptides: Injection site reactions (redness, swelling) Headaches (especially GH peptides initially) Water retention (GH peptides, GLP-1s) Nausea (GLP-1s, Melanotan II) When to stop: Severe allergic reaction (hives, difficulty breathing) Persistent severe side effects Unexplained symptoms Lack of improvement after reasonable trial Get baseline and follow-up bloodwork Before starting peptides: Basic metabolic panel Liver and kidney function Thyroid panel Relevant hormones (testosterone, IGF-1, etc.) During use: Follow-up testing every 3-4 months Monitor markers relevant to your peptides Adjust protocols based on results Legal and regulatory awareness Understand status: FDA-approved peptides require prescription Research peptides are gray area (legal to possess, not approved for human use) Athletic drug testing includes most peptides (WADA banned) See our are peptides legal guide for complete regulatory information
Our body naturally produces glutathione, but levels decrease significantly as we age
Methylcobalamin (Methyl B12) : Already bioactive, bypasses the liver, supports the nervous system, detoxification, and methylation directly
During the retention trial that occurred 24 h later, mice were placed in the illuminated chamber, and the latency to enter the dark chamber was recorded (i.e., step-through latency)
Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte
